---
title: "Clover Health releases transcript of 2Q26 supplemental Q&A on earnings call"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296533818.md"
description: "Clover Health released a Q2 2026 supplemental Q&A transcript featuring CEO Andrew Toy. Key highlights include cohort maturation driving profitability, with year-3 members generating $155 more PMPM in gross profit than year-1. Year-3 cohorts showed an 18% better Medical Care Ratio (MCR). CMS rated Clover’s plans at 4.5 Stars for 2027. Counterpart Health is prioritizing lives under management with real-time value-based payment models under consideration."
datetime: "2026-08-20T20:34:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296533818.md)
  - [en](https://longbridge.com/en/news/296533818.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296533818.md)
generator: "portal-rs"
---

# Clover Health releases transcript of 2Q26 supplemental Q&A on earnings call

-   Clover Health posted a 2Q26 supplemental shareholder Q&A transcript featuring remarks from CEO Andrew Toy. \* Cohort maturation under Clover Assistant cited as key driver, with year-3 members generating about $155 PMPM more insurance gross profit than year-1. \* Year-3 Clover Assistant-managed cohort showed an MCR about 18% better than non-assisted members, framed as compounding economics over time. \* CMS rated Clover’s PPO and HMO plans at 4.5 Stars for the 2027 payment year; management said it is operating on that basis. \* Counterpart Health positioned to prioritize lives under management and demonstrated impact before material financial contribution, with “real-time value-based payment” models under consideration. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clover Health Investments Corp. published the original content used to generate this news brief on August 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CLOV.US](https://longbridge.com/en/quote/CLOV.US.md)

## Related News & Research

- [Clover Health Chief Legal Officer Karen Soares disposes of 51,700 common shares for $233,167](https://longbridge.com/en/news/293257698.md)
- [Clover Health Q2 revenue rises 56%, beating estimates on memership growth](https://longbridge.com/en/news/295008626.md)
- [British American Tobacco announces Q2 2026 dividend of R$ 0.82 per unit, payable Aug. 25](https://longbridge.com/en/news/296633320.md)
- [Hello Heart study links heart failure program to $7,001 lower medical spend per user](https://longbridge.com/en/news/296369274.md)
- [MOLN: Cash of CHF 68M supports advancing DARPin oncology pipeline, with key data expected in 2026](https://longbridge.com/en/news/296862063.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**